Ostrum Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Ostrum Asset Management's JNJ Position: Q1 2026 in Review
Ostrum Asset Management reduced its Johnson & Johnson (JNJ) stake by 23% in Q1 2026, selling an estimated $3.8M and leaving 55,262 shares worth $13.5M. The position accounts for 0.76% of the portfolio, ranked #28.
Ostrum Asset Management first reported a position in JNJ in Q1 2023 and has held it in 13 quarters since. The position peaked at $14.8M in Q4 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Ostrum Asset Management held 55,262 shares of Johnson & Johnson worth $13.5M as of Q1 2026.
- Ostrum Asset Management sold 16,302 Johnson & Johnson shares in Q1 2026, an estimated $3.8M.
- Johnson & Johnson made up 0.76% of Ostrum Asset Management's portfolio in Q1 2026, its #28 holding.
- Ostrum Asset Management first reported a position in Johnson & Johnson in Q1 2023 and has held it in 13 quarters since.
- Ostrum Asset Management's Johnson & Johnson position peaked at $14.8M in Q4 2025.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.